Smoking by people with mental illness and benefits of smoke-free mental health services
J Campion, K Checinski, J Nurse… - Advances in Psychiatric …, 2008 - cambridge.org
Smoking is the largest single cause of preventable illness in the UK. Those with mental
health problems smoke significantly more and are therefore at greater risk. The new Health …
health problems smoke significantly more and are therefore at greater risk. The new Health …
Varenicline augmentation in depressed smokers: an 8-week, open-label study.
Objective: To assess possible antidepressant effects of varenicline augmentation in
outpatients with treatment-resistant depressive disorders and nicotine dependence …
outpatients with treatment-resistant depressive disorders and nicotine dependence …
Smoking patterns during pregnancy and postnatal period and depressive symptoms
MR Munafò, J Heron, R Araya - Nicotine & Tobacco Research, 2008 - academic.oup.com
We investigated the relationship between smoking status and depression symptom score in
a large prospective cohort of women (n= 7,089) followed at regular intervals during and …
a large prospective cohort of women (n= 7,089) followed at regular intervals during and …
Smoking cessation and depressive symptoms at 1-, 3-, 6-, and 12-months follow-up
Background The relationship between tobacco and depressive symptoms has been
examined. However, there is little information on the evolution of these symptoms when an …
examined. However, there is little information on the evolution of these symptoms when an …
Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment
Introduction: The question of whether abstinence during the months following a planned quit
attempt exacerbates or improves depressive symptoms is an important clinical issue. Extant …
attempt exacerbates or improves depressive symptoms is an important clinical issue. Extant …
The nicotinic acetylcholine receptor as a target for antidepressant drug development
An important new area of antidepressant drug development involves targeting the nicotinic
acetylcholine receptor (nAChR). This receptor, which is distributed widely in regions of the …
acetylcholine receptor (nAChR). This receptor, which is distributed widely in regions of the …
The impact of smoking cessation on schizophrenia and major depression
M Ragg, R Gordon, T Ahmed… - Australasian …, 2013 - journals.sagepub.com
Objective: This review sought to determine whether quitting smoking behaviour places
people with a history of schizophrenia or major depression at risk of worsening symptoms or …
people with a history of schizophrenia or major depression at risk of worsening symptoms or …
[HTML][HTML] Tabaquismo y depresión
A Moreno Coutiño, ME Medina-Mora Icaza - Salud mental, 2008 - scielo.org.mx
La intención del presente trabajo es la de reseñar información actualizada sobre el
tabaquismo y la depresión, a partir de una revisión de la base de datos PubMed. La fecha …
tabaquismo y la depresión, a partir de una revisión de la base de datos PubMed. La fecha …
Review of smoking cessation treatments for people with mental illness
J Campion, K Checinski, J Nurse - Advances in psychiatric treatment, 2008 - cambridge.org
This article reviews the current literature regarding treatments for smoking cessation in both
the general population and in those with mental health problems. The gold-standard …
the general population and in those with mental health problems. The gold-standard …
Use of cigarettes to improve affect and depressive symptoms in a longitudinal study of adolescents
Smoking to alleviate negative affect or improve physiological functioning (ie, self-
medication) is one explanation for the association between depression and smoking in …
medication) is one explanation for the association between depression and smoking in …